- $1.01bn
- $1.15bn
- $1.36bn
- 78
- 71
- 63
- 81
Annual income statement for Angi, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,326 | 1,468 | 1,619 | 1,764 | 1,359 |
| Cost of Revenue | |||||
| Gross Profit | 1,280 | 1,295 | 1,345 | 1,427 | 1,296 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,286 | 1,475 | 1,688 | 1,840 | 1,385 |
| Operating Profit | 40.4 | -6.82 | -69 | -75.6 | -26.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 33.6 | -19.3 | -93.9 | -94.6 | -28.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 35.3 | -4.16 | -64 | -89.2 | -30 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 34.8 | -6.28 | -71.4 | -128 | -40.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 34.8 | -6.28 | -71.4 | -128 | -40.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.065 | -0.012 | -0.128 | -0.178 | -0.061 |